Brahim Bookhart

1.9k total citations
112 papers, 1.4k citations indexed

About

Brahim Bookhart is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Brahim Bookhart has authored 112 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 48 papers in Internal Medicine and 23 papers in Hematology. Recurrent topics in Brahim Bookhart's work include Atrial Fibrillation Management and Outcomes (51 papers), Venous Thromboembolism Diagnosis and Management (48 papers) and Health Systems, Economic Evaluations, Quality of Life (21 papers). Brahim Bookhart is often cited by papers focused on Atrial Fibrillation Management and Outcomes (51 papers), Venous Thromboembolism Diagnosis and Management (48 papers) and Health Systems, Economic Evaluations, Quality of Life (21 papers). Brahim Bookhart collaborates with scholars based in United States, Canada and Belgium. Brahim Bookhart's co-authors include Patrick Lefèbvre, Samir H. Mody, François Laliberté, Jeff Schein, Joyce LaMori, Edith A. Nutescu, Craig I Coleman, Mei Sheng Duh, Catherine Tak Piech and Concetta Crivera and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brahim Bookhart

107 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brahim Bookhart United States 20 668 649 211 206 205 112 1.4k
Hemant Phatak United States 22 1.0k 1.5× 390 0.6× 277 1.3× 187 0.9× 45 0.2× 87 1.7k
Carmen Suárez Spain 22 1.0k 1.5× 709 1.1× 144 0.7× 465 2.3× 123 0.6× 87 1.8k
Sue Hee Sung United States 21 1.1k 1.7× 217 0.3× 137 0.6× 231 1.1× 48 0.2× 65 1.6k
Isabelle Mahé France 27 1.5k 2.2× 1.3k 2.0× 122 0.6× 385 1.9× 215 1.0× 171 2.4k
Vincent J. Willey United States 23 372 0.6× 169 0.3× 483 2.3× 552 2.7× 46 0.2× 91 1.8k
Karin A. H. Kaasjager Netherlands 18 383 0.6× 184 0.3× 46 0.2× 181 0.9× 46 0.2× 69 1.1k
Desiderius P.M. Brandjes Netherlands 13 804 1.2× 1.0k 1.6× 74 0.4× 476 2.3× 514 2.5× 26 1.7k
Lara N. Roberts United Kingdom 24 490 0.7× 781 1.2× 23 0.1× 442 2.1× 299 1.5× 93 1.9k
Marcel M.C. Hovens Netherlands 21 1.2k 1.8× 1.1k 1.7× 32 0.2× 495 2.4× 154 0.8× 50 2.0k
Rachel B. Fissell United States 16 407 0.6× 118 0.2× 78 0.4× 175 0.8× 102 0.5× 31 1.7k

Countries citing papers authored by Brahim Bookhart

Since Specialization
Citations

This map shows the geographic impact of Brahim Bookhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brahim Bookhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brahim Bookhart more than expected).

Fields of papers citing papers by Brahim Bookhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brahim Bookhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brahim Bookhart. The network helps show where Brahim Bookhart may publish in the future.

Co-authorship network of co-authors of Brahim Bookhart

This figure shows the co-authorship network connecting the top 25 collaborators of Brahim Bookhart. A scholar is included among the top collaborators of Brahim Bookhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brahim Bookhart. Brahim Bookhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Alberts, Mark J., et al.. (2023). Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study. Advances in Therapy. 40(4). 1750–1764. 3 indexed citations
4.
Alberts, Mark J., et al.. (2023). Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation. Advances in Therapy. 40(5). 2339–2354. 1 indexed citations
5.
Alberts, Mark J., et al.. (2023). Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy. Current Medical Research and Opinion. 39(9). 1279–1286. 1 indexed citations
6.
McComsey, Grace A., Bruno Émond, Aditi Shah, et al.. (2022). Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy. Infectious Diseases and Therapy. 11(5). 1883–1899. 12 indexed citations
7.
Blonde, Lawrence, Charmi Patel, Bingcao Wu, et al.. (2020). Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States. Advances in Therapy. 38(1). 594–606. 7 indexed citations
8.
9.
Young, James B., Marjolaine Gauthier‐Loiselle, Robert A. Bailey, et al.. (2018). Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovascular Diabetology. 17(1). 118–118. 31 indexed citations
10.
McHorney, Colleen A., Concetta Crivera, François Laliberté, et al.. (2015). Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure. Circulation. 132(suppl_3). 1 indexed citations
11.
LaMori, Joyce, Omar Shoheiber, Samir H. Mody, & Brahim Bookhart. (2014). Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States. Clinical Therapeutics. 37(1). 62–70. 55 indexed citations
12.
Page, Robert L., Vahram Ghushchyan, Brian Gifford, et al.. (2014). Hidden Costs Associated With Venous Thromboembolism. Journal of Occupational and Environmental Medicine. 56(9). 979–985. 13 indexed citations
13.
Bookhart, Brahim, Lloyd Haskell, Luke Bamber, et al.. (2014). Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program. Journal of Medical Economics. 17(10). 691–695. 37 indexed citations
14.
Lang, Kathleen, Aarti A. Patel, Brahim Bookhart, et al.. (2014). Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis. Journal of Thrombosis and Thrombolysis. 39(4). 434–442. 6 indexed citations
15.
Laliberté, François, Craig I Coleman, Brahim Bookhart, et al.. (2014). Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants. Current Medical Research and Opinion. 30(8). 1513–1520. 16 indexed citations
16.
Limone, Brendan, et al.. (2013). Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials. Thrombosis Research. 132(4). 420–426. 41 indexed citations
17.
Papatheofanis, Frank J., Brahim Bookhart, Erik Muser, & Catherine Tak Piech. (2008). An Examination of Productivity and Resource Utilization Associated With Epoetin Alfa Treatment in Employees With Predialysis Chronic Kidney Disease. Journal of Occupational and Environmental Medicine. 50(5). 584–589. 6 indexed citations
18.
Larholt, Kay, Chris L. Pashos, Qin Wang, et al.. (2008). Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE). Clinical Drug Investigation. 28(3). 159–167. 7 indexed citations
19.
Papatheofanis, Frank J., Cynthia A. Smith, Samir H. Mody, et al.. (2007). Dosing Patterns, Hematologic Outcomes, and Costs of Erythropoietic Agents in Anemic Predialysis Chronic Kidney Disease Patients From an Observational Study. American Journal of Therapeutics. 14(4). 322–327. 7 indexed citations
20.
Bookhart, Brahim, et al.. (2002). Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.. PubMed. 8(10 Suppl). S255–61. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hemant Phatak Breakdown of academic impact, for papers by Carmen Suárez Breakdown of academic impact, for papers by Sue Hee Sung Breakdown of academic impact, for papers by Isabelle Mahé Breakdown of academic impact, for papers by Vincent J. Willey Breakdown of academic impact, for papers by Karin A. H. Kaasjager Breakdown of academic impact, for papers by Desiderius P.M. Brandjes Breakdown of academic impact, for papers by Lara N. Roberts Breakdown of academic impact, for papers by Marcel M.C. Hovens Breakdown of academic impact, for papers by Rachel B. Fissell
Rankless by CCL
2026